Actualités



Retour


14/04/2020
ANNUAL REPORT 2019
About Asarina Pharma. We are a Swedish biotech company developing Sepranolone, the world’s first dedicated treatment for premenstrual dysphoric disorder (PMDD) and other menstrual-related conditions. Our product pipeline is built on over 40 years’ research into menstrual-related disorders like PMDD and menstrual migraine. [...]

Télécharger le fichier pdf





X

X